Effectiveness and cost-effectiveness of supplemental glutamine dipeptide in total parenteral nutrition therapy for critically ill patients: A discrete event simulation model based on Italian data

International Journal of Technology Assessment in Health Care

Volumn 28, Issue 1, 2012, Pages 22-28

  Pradelli, Lorenzo ^a   Iannazzo, Sergio ^a   Zaniolo, Orietta ^a   Muscaritoli, Maurizio ^b   Eandi, Mario ^c  

^a Adres Health Economics ^*  (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

Author keywords

alanylglutamine; Intensive care unit; Total parenteral nutrition

Indexed keywords

ALANYLGLUTAMINE; CLINICAL DATA; CLINICAL OUTCOME; COST DATA; CRITICALLY-ILL PATIENTS; DEATH RATES; DIPEPTIDE; DISCRETE-EVENT SIMULATION MODEL; EFFICACY DATA; INFECTION RATES; INTENSIVE CARE; META-ANALYSIS; MORTALITY RATE; RANDOM EFFECTS; TOTAL COSTS; TREATMENT COSTS; UNCERTAIN PARAMETERS; VALIDATION PROCESS;

AMINO ACIDS; COSTS; DISCRETE EVENT SIMULATION; INTENSIVE CARE UNITS; NUTRITION; PATIENT TREATMENT; PEPTIDES; POPULATION STATISTICS; SENSITIVITY ANALYSIS;

COST BENEFIT ANALYSIS;

ALANYLGLUTAMINE DIPEPTIDE; DIPEPTIDE; UNCLASSIFIED DRUG;

ARTICLE; COST EFFECTIVENESS ANALYSIS; CRITICALLY ILL PATIENT; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; SIMULATION; SUPPLEMENTATION; TOTAL PARENTERAL NUTRITION;

COMPUTER SIMULATION; COST-BENEFIT ANALYSIS; CRITICAL ILLNESS; DIETARY SUPPLEMENTS; GLUTAMINE; HUMANS; INTENSIVE CARE UNITS; ITALY; LENGTH OF STAY; MODELS, ECONOMIC; PARENTERAL NUTRITION, TOTAL; TIME FACTORS; WASTING SYNDROME;

EID: 84859084989     PISSN: 02664623     EISSN: 14716348     Source Type: Journal    
DOI: 10.1017/S0266462311000705     Document Type: Article

References (26)

1. Agenzia Nazionale per I Servizi Sanitari Regionali. Ricoveri, Personale e spesa delle Aziende Ospedaliere (2003).
2. Ricoveri-personale-e-spesa-aziende-ospedaliere-(2003).pdf (accessed May 2009).
3. Cai G, Yan J, Zhang Z, Yu Y. Immunomodulatory effects of glutamineenriched nutritional support in elderly patients with severe sepsis: A prospective, randomized, controlled study. J Organ Dysfunct. 2008;4:31-37. (Pubitemid 351197946)
4. Canadian Clinical Practice Guidelines for Nutrition Support (2007). Critical Care Nutrition. index.php?option=com-content&task=view&id= 17&Itemid=40 (accessed May 2009).
5. Cavallo MC, Lazzaro C, Tabacchi M, et al. [Cost of ICU in Italy. Results from an empirical study on a sample of 12 hospitals]. Minerva Anestesiol. 2001;67:41-53.
6. Dechelotte P, Hasselmann M, Cynober L, et al. L-alanyl-L-glutamine dipeptide-supplemented total parenteral nutrition reduces infectious complications and glucose intolerance in critically ill patients: The French controlled, randomized, double-blind, multicenter study. Crit Care Med. 2006;34:598-604.
7. Duska F, Fric M,Waldauf P, et al. Frequent intravenous pulses of growth hormone together with glutamine supplementation in prolonged critical illness after multiple trauma: Effects on nitrogen balance, insulin resistance, and substrate oxidation. Crit Care Med. 2008;36:1707-1713.
8. Estivariz CF, Griffith DP, Luo M, et al. Efficacy of parenteral nutrition supplemented with glutamine dipeptide to decrease hospital infections in critically ill surgical patients. JPEN J Parenter Enteral Nutr. 2008;32:389-402. (Pubitemid 351875934)
9. Fuentes-Orozco C, Anaya-Prado R, Gonzalez-Ojeda A, et al. L-alanyl- L-glutamine-supplemented parenteral nutrition improves infectious morbidity in secondary peritonitis. Clin Nutr. 2004;23:13-21. (Pubitemid 38219647)
10. Fuentes-Orozco C, CerVantes-Guevara G, Mucino-Hernandez I, et al. L-alanyl-L-glutamine-supplemented parenteral nutrition decreases infectious morbidity rate in patients with severe acute pancreatitis. JPEN J Parenter Enteral Nutr. 2008;32:403-411. (Pubitemid 351875937)
11. Goeters C, Wenn A, Mertes N, et al. Parenteral L-alanyl-L-glutamine improves 6-month outcome in critically ill patients. Crit Care Med. 2002;30:2032-2037.
12. Griffiths RD, Jones C, Palmer TE. Six-month outcome of critically ill patients given glutamine-supplemented parenteral nutrition. Nutrition.1997;13: 295-302.
13. Informatore Farmaceutico - 69a edizione. Milano: Ed. Elsevier Masson; 2009.
14. Luo M, Bazargan N, Griffith DP, et al. Metabolic effects of enteral versus parenteral alanyl-glutamine dipeptide administration in critically ill patients receiving enteral feeding: A pilot study. Clin Nutr. 2008;27:297-306.
15. Novak F, Heyland DK, Avenell A, Drover JW, Su X. Glutamine supplementation in serious illness: A systematic review of the evidence. Crit Care Med. 2002;30:2022-2029.
16. Orsi GB, Di Stefano L, Noah N. Hospital-acquired, laboratory-confirmed bloodstream infection: Increased hospital stay and direct costs. Infect Control Hosp Epidemiol. 2002;23:190-197. (Pubitemid 34297272)
17. Oudemans-Van Straaten H, Bosman R, Treskes M, Van der Spoel H, Zandstra D. Plasma glutamine depletion and patient outcome in acute ICU admissions. Intensive Care Med. 2001;27:84-90. (Pubitemid 32208973)
18. Ṕerez-B́arcena J, Regueiro V, Marśe P, et al. Glutamine as a modulator of the immune system of critical care patients: Effect on toll-like receptor expression. A preliminary study. Nutrition. 200824:522-527.
19. Powell-Tuck J, Jamieson CP, Bettany GE, et al. A double blind, randomised, controlled trial of glutamine supplementation in parenteral nutrition. Gut. 1999;45:82-88. (Pubitemid 29301850)
20. Progetto MARGHERITA - Rapporto 2007. Gruppo Italiano per la Valutazione degli Interventi in Terapia Intensiva (GIVITI). Sestante Edizioni - Bergamo, 2008
21. Sahin H, Mercanligil SM, InançN, Ok E. Effects of glutamineenriched total parenteral nutrition on acute pancreatitis. Eur J Clin Nutr. 2007;61:1429-1434. (Pubitemid 350245918)
22. Spiegelhalter D, Abrams K, Myles J. Bayesian approaches to clinical trials and health-care evaluation. New York: Wiley-Blackwell; 2003.
23. Wessner B, Strasser E, Spittler A, Roth E. Effect of single and combined supply of glutamine, glycine, N-acetylcysteine, and R,S-alpha-lipoic acid on glutathione content of myelomonocytic cells. Clin Nutr. 2003;22:515-522. (Pubitemid 37455717)
24. Wischmeyer PE, Lynch J, Liedel J, et al. Glutamine administration reduces Gram-negative bacteremia in severely burned patients: A prospective, randomized, double-blind trial versus isonitrogenous control. Crit Care Med. 2001;29:2075-2080. (Pubitemid 33063533)
25. Xian-Li H, Qing-Jiu M, Jian-Guo L, Yan-Kui C, Xi-Lin D. Effect of total parenteral nutrition (TPN) with and without glutamine dipeptide supplementation on outcome in severe acute pancreatitis (SAP). Clin Nutr. 2004;(Suppl 1):43-47.
26. ZhouY-P, Jiang Z-M, SunY-H, He G-Z, ShuH. The effects of supplemental glutamine dipeptide on gut integrity and clinical outcome after major escharectomy in severe burns: A randomized, double-blind, controlled clinical trial. Clin Nutr Suppl. 2004;1:55-60. (Pubitemid 40103989)